Free & confidential case reviews · No obligation (877) 342-6154

Home / Cases / Roundup

Toxic ExposureLimited intake

Roundup Cancer Claims

Diagnosed with non-Hodgkin lymphoma after using Roundup weed killer? Find out what options remain.

StatusLimited intake
Case typeToxic Exposure
Case reviewFree & confidential
Last updatedNovember 2026

About this case

Roundup's active ingredient, glyphosate, was classified as a probable human carcinogen by the International Agency for Research on Cancer (IARC) in 2015. Users diagnosed with non-Hodgkin lymphoma sued Monsanto (now Bayer).

Where the case stands

In June 2026 the U.S. Supreme Court ruled 7-2 in Monsanto v. Durnell that federal law preempts many state failure-to-warn claims, which is expected to end thousands of lawsuits. A separate $7.25 billion class settlement is still moving forward. A reviewer can tell you whether you may be eligible for settlement compensation.

Status last reviewed November 2026. Lawsuit developments change often.

Who may qualify

  • You used Roundup or another glyphosate weed killer regularly
  • You (or a loved one) were diagnosed with non-Hodgkin lymphoma

Injuries and conditions involved

Non-Hodgkin lymphoma (NHL)B-cell and T-cell lymphomasChronic lymphocytic leukemia (CLL)

Free · Confidential · About 2 minutes

Find out if you qualify

Answer a few quick questions about your Roundup claim. There's no cost and no obligation.

See If I Qualify

Prefer to talk? Call (877) 342-6154

Free Case Review